Slashing Two-wheeled Accidents by Leveraging Eyecare

NCT05466955 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 625

Last updated 2025-07-17

No results posted yet for this study

Summary

STABLE is a stepped-wedge cluster randomised controlled trial and its primary aim is to determine whether the provision of spectacles for the correction of myopia can reduce the average number of crash-near-crash (CNC) events among eligible motorcycle drivers in Vietnam as measured under naturalistic driving conditions with the Data Acquisition System (DAS).

STABLE is designed to assess the impact of vision correction on the safety of road users in a a Low and Middle income countries (LMIC) setting. A positive trial outcome would demonstrate the safety benefits of vision correction and would create pressure for tighter regulation of drivers' vision and the promotion of vision correction.

The study will be conducted in the peri-urban universities in Ho Chi Minh City, Vietnam and 625 students from five universities will be recruited into the trial.

Before conducting the main trial, a pilot of 35 students will be recruited to test DAS and build CNC dictionary.

Duration of the trial is 33 months from enrolment to completion of primary analysis, with 18 months for data collection.

Study participants can be both male and female motorcycle drivers aged 18 to 23 years years with at least one year of driving experience; they must use their motorcycle as their primary means of transport; drive at least 25 km per week and present with un- or under-corrected myopia that can be corrected with spectacles.

Participants with any ocular or systemic abnormality affecting vision, other than un-or under-corrected myopia will be excluded from the trial.

STABLE's primary outcome is CNC events per 1,000 km driven the DAS mounted to the motorcycles of trial participants. An interim analysis of the primary outcome will take place 9 months after data collection begins. The interim analysis will be reviewed by the trial's Data Monitoring and Ethics Committee. Unless a change is needed because of this review, the trial's primary analysis will take place 18 months after the DAS units are fitted to participants' motorcycle).

Compliance with study glasses; self-reported visual function (driving-adapted Visual Function Questionnaire-25 \[VFQ-25\]); Dula Dangerous Driving Index (DDDI), for all crashes; self-reported CNC events for comparison with recorded CNC events and total delivery cost per CNC event avoided with the intervention (indicator of cost-effectiveness).

Conditions

  • Myopia

Interventions

DEVICE

Free eye glasses for un or under-corrected myopia

All participants randomised to the intervention group will be provided with free eye glasses

Sponsors & Collaborators

  • L.V. Prasad Eye Institute

    collaborator OTHER
  • University of Medicine and Pharmacy at Ho Chi Minh City

    collaborator OTHER
  • Asia Injury Prevention Foundation

    collaborator UNKNOWN
  • Clearly

    collaborator OTHER
  • Belfast Health and Social Care Trust

    collaborator OTHER
  • Transport Development and Strategy Institute, Ministry of Transport, Vietnam

    collaborator UNKNOWN
  • EyeCare Foundation

    collaborator UNKNOWN
  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • Tô Gia Kiên, PhD · University of Medicine and Pharmacy at Ho Chi Minh City Vietnam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
23 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-22
Primary Completion
2026-06-30
Completion
2027-12-31

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05466955 on ClinicalTrials.gov